$116.79 0.9%
LNTH Stock Price vs. AI Score (Last 150 days)
Data gathered: July 21

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

About Lantheus

Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide.


Lantheus
Price $116.79
Target Price Sign up
Volume 700,900
Market Cap $8.1B
Year Range $51.07 - $123.62
Dividend Yield 0%
PE Ratio 17.8
Revenue per Employee $1,928,617
Earnings Date July 31 '24
Industry Biotechnology

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q1 '24365M232M242M131M186M1.690
Q4 '23349M237M230M103M181M1.750
Q3 '23315M196M200M132M168M1.470
Q2 '23317M185M203M94M132M1.540
Q1 '23296M415M77M-2.8M-2.7M1.470

Insider Transactions View All

Sabens Andrea filed to sell 60,420 shares at $125.
July 17 '24
Sabens Andrea filed to sell 62,216 shares at $123.2.
July 17 '24
Pruden Gary J filed to sell 11,978 shares at $95.
July 12 '24
Sabens Andrea filed to sell 62,557 shares at $79.8.
June 17 '24
Blanchfield Paul filed to sell 101,498 shares at $80.8.
June 4 '24

What is the Market Cap of Lantheus?

The Market Cap of Lantheus is $8.1B.

What is Lantheus' PE Ratio?

As of today, Lantheus' PE (Price to Earnings) ratio is 17.8.

How Many People Work at Lantheus?

As of our latest update, Lantheus employed approximately 698 people worldwide. However, it's important to note that Lantheus' workforce size can fluctuate due to the company's growth, restructuring, or strategic shifts, so the current number of employees may be different.

What is Lantheus' revenue per employee?

$1,928,617. To calculate Lantheus' revenue per employee, we divide the company's total revenue in the last 4 quarters by its total number of employees.

When does Lantheus report earnings?

Lantheus will report its next earnings on July 31 '24.

What is the current stock price of Lantheus?

Currently, the price of one share of Lantheus stock is $116.79.

How can I analyze the LNTH stock price chart for investment decisions?

The LNTH stock price chart above provides a comprehensive visual representation of Lantheus' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Lantheus shares. Our platform offers an up-to-date LNTH stock price chart, along with technical data analysis and alternative data insights.

Does LNTH offer dividends to its shareholders?

As of our latest update, Lantheus (LNTH) does not offer dividends to its shareholders. Investors interested in Lantheus should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of Lantheus?

Some of the similar stocks of Lantheus are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.